{"id":"W2139097830","doi":"10.1586/14737140.3.3.295","title":"Advances in targeted therapy for chronic myeloid leukemia","year":2003,"lang":"en","type":"review","venue":"Expert Review of Anticancer Therapy","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Myeloid leukemia; Medicine; Imatinib mesylate; Imatinib; Leukemia; Targeted therapy; Immunology; Myeloid; Cancer research; Oncology; Internal medicine; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004994332,0.0007182156,0.001053752,0.001502974,0.0002610815,0.0006019819,0.0005709564,0.0007637219,0.003960806],"category_scores_gemma":[0.0003445213,0.0001560654,0.0004182156,0.001453834,0.000277851,0.0007948505,0.0005388684,0.001463226,0.002822143],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005046059,"about_ca_system_score_gemma":0.000739814,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008761892,"about_ca_topic_score_gemma":0.001855621,"domain_scores_codex":[0.9998246,0.0000330547,0.00001999237,0.00002548493,0.0000814836,0.00001532152],"domain_scores_gemma":[0.999859,0.00005371319,0.00002303497,0.000006091132,0.00004238698,0.0000157687],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006139113,0.0001099149,0.0001225013,0.006491258,0.00005901754,0.0002961534,0.00004496185,0.0003283773,0.004727168,0.003484311,0.01938293,0.964892],"study_design_scores_gemma":[0.00003259287,0.0001376677,0.0006177863,0.001242076,0.00006194279,0.001664626,0.00002575684,0.00009621218,0.0008518177,0.001667444,0.9935912,0.00001088107],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002009689,0.9971436,0.0003224972,0.0003165674,0.000201045,0.000008124553,0.00001175518,0.000009105797,0.001786418],"genre_scores_gemma":[0.0008699384,0.9973772,0.0004329954,0.0002212541,0.0001597523,0.000008977599,0.000024166,0.000001393158,0.0009042517],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003960806,"threshold_uncertainty_score":0.01325023,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03901782163630336,"score_gpt":0.4007243942037427,"score_spread":0.3617065725674393,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}